DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us

News


Search news :

AFORRD results presented at IDF WDC2006 Cape Town

07-Dec-2006
News Image The results of the AFORRD trial were presented at the International Diabetes Federation Congress in Cape Town on Thursday 7th December 2006
A copy of the press release is attached.


[Link]

DREAM drug washout study results

07-Dec-2006
News Image DREAM drug washout study results released at IDF WDC2006 Cape Town

PON2 polymorphisms and renal dysfunction (UKPDS 76)

17-Nov-2006
News Image Paraoxonase2 (PON2) Polymorphisms and Development of Renal Dysfunction in Type 2 Diabetes: UKPDS 76
Calle R, McCarthy MI, Banerjee P, Zeggini E, Cull CA, Thorne KI, Wiltshire S, Terra S, Meyer D, Richmond J, Mancuso J, Milos P, Fryburg D, Holman RR
Diabetologia 2006;49:2892-2899

[Link]

Characteristics of Type 2 diabetic patients in North America and Europe (ADOPT)

17-Nov-2006
News Image A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe
Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, Heise MA, Jones NP, O'Neill MC, Freed MI, Kahn SE, Herman WH for the ADOPT Study Group
Diabetic Medicine 2006;23:1289-1294

[Link]

Is there a need for a clinical screening tool for autoimmune diabetes in adults?

30-Oct-2006


[Link]

Hypoglycaemia in type 2 diabetes (UKPDS 73)

26-Oct-2006
News Image Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS 73
Wright AD, Cull CA, Macleod KM, Holman RR for the UKPDS Group
Journal of Diabetes and its Complications 2006;20:402-408

[Link]

Download DREAM trial results slides

15-Sep-2006
News Image

[Link]

DREAM trial results

13-Sep-2006
News Image

[Link]

Obesity and CRP in type 2 diabetes (ADOPT)

01-Aug-2006
News Image Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes
Steven E. Kahn, Bernard Zinman, Steven M....

[Read more...]

Impact of glycemic control on macrovascular disease

05-Jul-2006
News Image Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
Christoph Stettler, Sabin Allemann, Peter J√ľni, Carole A. Cull, Rury R....

[Read more...]

ADA/EASD consensus algorithm for managing hyperglycaemia

29-Jun-2006
News Image Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
David M Nathan, John B Buse, Mayer B Davidson, Robert J Heine, Rury R Holman, Robert Sherwin, Bernard Zinman

Published simultaneously in:

Diabetes Care (2006); 29: 1963-1972

and

Diabetologia (2006); 49: 1711-1721

Impact of Visual Acuity on Quality of Life

28-Jun-2006
News Image Assessing the Impact of Visual Acuity on Quality of Life in Individuals With Type 2 Diabetes Using the Short Form-36
Philip M Clarke, Judit Simon, Carole A Cull, Rury R Holman
Diabetes Care 2006; 29: 1506-1511

OBJECTIVE- We sought to ascertain quality-of-life measures and utility values associated with visual acuity in type 2 diabetes.
RESEARCH DESIGN AND METHODS- The Medical Outcome Study Short Form with 36 items (SF-36) was administered to 4,051 individuals with type 2 diabetes who were enrolled in the Lipids in Diabetes Study, and their best attainable vision was determined using an Early Treatment of Diabetic Retinopathy Study chart, expressed as a LogMAR score....

[Read more...]

Combined effects of glycaemia and blood pressure in type 2 diabetes (UKPDS 75)

01-Jun-2006
News Image Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)
I.M....

[Read more...]

VNTR and LADA susceptibility

31-May-2006
News Image The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults
Minal Desai, Eleftheria Zeggini, Virginia A. Horton, Katharine R....

[Read more...]

Risk factors for renal dysfunction (UKPDS 74)

30-May-2006
News Image Risk Factors for Renal Dysfunction in Type 2 Diabetes : UK Prospective Diabetes Study 74
Ravi Retnakaran, Carole A. Cull, Kerensa I....

[Read more...]

Joint Servier/OCDEM Meeting for Specialist Registrars

15-May-2006
News Image Beyond The Boundary
Cutting Edge Issues for Emerging Diabetologists.
Venue: 26-27th October 2006, Eynsham Hall, Oxford


This joint OCDEM and Servier meeting is for specialist registrars who are within two years of completing their training in diabetes and seeking to practice as a consultant....

[Read more...]

Thames Valley Diabetes Research Network

15-May-2006
News Image Oxford University researchers and the Oxford Radcliffe Hospitals Trust will lead one of eight new Local Research Networks for diabetes across the UK, working with hospitals and patients throughout the Thames Valley area to develop prevention methods and treatments for diabetes.

The national Diabetes Research Network, with its eight dedicated Local Research Networks, was announced last week by the Department of Health and the UK Clinical Research Network....

[Read more...]

Long-term efficacy of sulfonylureas

04-May-2006
News Image Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective
Rury R. Holman
Metabolism Clinical and Experimental 55 (Suppl 1) (2006) S2-S5

Abstract
The United Kingdom Prospective Diabetes Study shows sulfonylureas to be an effective first-line therapy for people with type 2 diabetes mellitus....

[Read more...]

Comment on PROactive study results

07-Jan-2006
Lancet 2006; 367:25-26

RR Holman, R Retnakaran, A Farmer and R Stevens

The PROactive study has provided an exploratory estimate of the relative risk reduction attributable to pioglitazone for a composite endpoint of all-cause mortality, non-fatal myocardial infarction, and stroke. Although this secondary endpoint was not prespecified and is not significant when adjusted for multiple testing, it is of interest because of the possibility that the observed 16% relative risk reduction might not be mediated through established macrovascular risk factors such as blood pressure, lipids, and glycaemia....

[Read more...]